MTOR and colorectal carcinoma: Overall, this result suggested that PLCG2 promoted tumor cell proliferation, invasion, metastasis, and EMT and inhibited apoptosis through activation of the Akt-mTOR signaling pathway, thereby facilitating CRC progression.